Literature DB >> 18192899

Genetic analysis of a relationship between macrocyclic lactone and benzimidazole anthelmintic selection on Haemonchus contortus.

Maria de Lourdes Mottier1, Roger K Prichard.   

Abstract

OBJECTIVES: We have found that in a laboratory strain of the nematode parasite of ruminants, Haemonchus contortus, repeated ivermectin treatment, in vivo in sheep, selected against TTC, coding for Phe, and for TAC, coding for Tyr, at codon 200 in beta-tubulin isotype 1. This 200Tyr single nucleotide polymorphism (SNP) has been associated with benzimidazole anthelmintic resistance. In this study, we investigated the alpha-tubulin and beta-tubulin sequences of 17 different field and laboratory strains/isolates of H. contortus with known treatment history and status for susceptibility or resistance to macrocyclic lactone (ML) or benzimidazole anthelmintics. BASIC
METHODS: DNA (genomic or cDNA) from 10 to 32 male parasites was sequenced for alpha-tubulin or beta-tubulin for each strain/isolate and the frequency of coding SNPs was compared between the different strains/isolates with known treatment history and drug resistance status. MAIN
RESULTS: We have analyzed alpha-tubulin and beta-tubulin isotypes 1 and 2 genes from the different H. contortus strains/isolates and found that repeated ivermectin or moxidectin (both ML anthelmintics) use changes the frequency of beta-tubulin isotype 1 alleles and selects for the following SNPs: either from TTC (Phe) to TAC (Tyr) at codon 200 or codon 167, or from GCA (Ala) to GAA (Glu) at codon 198. 200Tyr and 167Tyr were associated with GTT (Val) or CTC/CTT (Leu) at codon 368, whereas 200Phe or 167Phe were associated with either ATT (Ile) or GTT (Val) at codon 368 in beta-tubulin isotype 1. The SNPs 200Tyr, 167Tyr in beta-tubulin isotype 1 have been described to confer benzimidazole resistance in nematodes and recently 198Ala has also been associated with benzimidazole resistance.
CONCLUSIONS: Although MLs exert their antiparasitic effect through binding to ligand-gated chloride channels, benzimidazoles interact with beta-tubulin. These genetic analyses indicate that there is a correlation between exposure and/or resistance to MLs and an increase in the frequency of the beta-tubulin alleles containing codons, which are determinant for benzimidazole resistance. ML use may predispose parasitic nematodes to benzimidazole resistance. This has major implications for parasite control programs dependent on MLs/benzimidazole rotations and on the use of ML/benzimidazole combination therapy, such as for human lymphatic filariasis and nematode control in ruminant livestock.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18192899     DOI: 10.1097/FPC.0b013e3282f4711d

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  34 in total

1.  Molecular and biological diagnostic tests for monitoring benzimidazole resistance in human soil-transmitted helminths.

Authors:  Aïssatou Diawara; Jan M Schwenkenbecher; Ray M Kaplan; Roger K Prichard
Journal:  Am J Trop Med Hyg       Date:  2013-03-04       Impact factor: 2.345

2.  Benzimidazole resistance in Haemonchus contortus recovered from farmed red deer.

Authors:  Gábor Nagy; Ágnes Csivincsik; Attila Zsolnai; László Sugár
Journal:  Parasitol Res       Date:  2016-06-01       Impact factor: 2.289

3.  Relative level of thiabendazole resistance associated with the E198A and F200Y SNPs in larvae of a multi-drug resistant isolate of Haemonchus contortus.

Authors:  Andrew C Kotze; Katie Cowling; Neil H Bagnall; Barney M Hines; Angela P Ruffell; Peter W Hunt; Glen T Coleman
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-03-03       Impact factor: 4.077

4.  Genetic Markers of Benzimidazole Resistance among Human Hookworms (Necator americanus) in Kintampo North Municipality, Ghana.

Authors:  Ambrose R Orr; Josephine E Quagraine; Peter Suwondo; Santosh George; Lisa M Harrison; Fabio Pio Dornas; Benjamin Evans; Adalgisa Caccone; Debbie Humphries; Michael D Wilson; Michael Cappello
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

5.  Genotypic and phenotypic evaluation for benzimidazole resistance or susceptibility in Haemonchus contortus isolates.

Authors:  Waleed M Arafa; Patricia J Holman; Thomas M Craig
Journal:  Parasitol Res       Date:  2016-12-28       Impact factor: 2.289

Review 6.  Anthelmintic resistance: markers for resistance, or susceptibility?

Authors:  R N Beech; P Skuce; D J Bartley; R J Martin; R K Prichard; J S Gilleard
Journal:  Parasitology       Date:  2010-09-09       Impact factor: 3.234

Review 7.  Is anthelmintic resistance a concern for the control of human soil-transmitted helminths?

Authors:  Jozef Vercruysse; Marco Albonico; Jerzy M Behnke; Andrew C Kotze; Roger K Prichard; James S McCarthy; Antonio Montresor; Bruno Levecke
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-10-14       Impact factor: 4.077

Review 8.  P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance.

Authors:  Anne Lespine; Cécile Ménez; Catherine Bourguinat; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-07       Impact factor: 4.077

9.  Genotypic analysis of β-tubulin in Onchocerca volvulus from communities and individuals showing poor parasitological response to ivermectin treatment.

Authors:  Mike Y Osei-Atweneboana; Daniel A Boakye; Kwablah Awadzi; John O Gyapong; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-02-12       Impact factor: 4.077

10.  Faecal Cyathostomin Egg Count distribution and efficacy of anthelmintics against cyathostomins in Italy: a matter of geography?

Authors:  Piermarino Milillo; Albert Boeckh; Rami Cobb; Domenico Otranto; Riccardo P Lia; Stefania Perrucci; Antonio Frangipane di Regalbono; Paola Beraldo; Georg von Samson-Himmelstjerna; Janina Demeler; Roberto Bartolini; Donato Traversa
Journal:  Parasit Vectors       Date:  2009-09-25       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.